Results 21 to 30 of about 232,776 (304)

Neurofibromatosis type 1 associated with hypophosphatemic osteomalacia due to hypersecretion of fibroblast growth factor 23: a case report

open access: yesJournal of Medical Case Reports, 2020
Background Neurofibromatosis type 1 is characterized by multiple café au lait spots and cutaneous and plexiform neurofibromas, and is one of the most common autosomal dominant hereditary disorders caused by mutations of the neurofibromatosis type 1 tumor
Takahiko Obo   +4 more
doaj   +1 more source

Fibroblast Growth Factor-23 (FGF-23) e Sindrome Cardiorenale

open access: yesGiornale di Clinica Nefrologia e Dialisi, 2015
non disponibile (Cardionephrology)
Luca Di Lullo   +6 more
doaj   +1 more source

Serum intact fibroblast growth factor 23 in healthy paediatric population

open access: yesOpen Medicine, 2021
It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent.
Stanczyk Malgorzata   +3 more
doaj   +1 more source

Fibroblast growth factor 23: fueling the fire [PDF]

open access: yesKidney International, 2016
In chronic kidney disease, systemic inflammation is common and associated with mortality. The present study demonstrates that fibroblast growth factor 23 (FGF23) contributes to uremic inflammation by increasing hepatic expression and secretion of inflammatory cytokines.
Hanudel, Mark   +2 more
openaire   +4 more sources

MicroRNA-297a regulates vascular calcification by targeting fibroblast growth factor 23 [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2016
Objective(s): Vascular calcification is one the major characteristics in patients with various types of chronic inflammatory disorders. MiRNAs have been shown to be involved in many normal biological functions as well as diseases; however, their role in ...
Shouhua Zheng   +6 more
doaj   +1 more source

Multiple faces of fibroblast growth factor-23 [PDF]

open access: yesCurrent Opinion in Nephrology and Hypertension, 2016
This review examines the role of fibroblast growth factor-23 (FGF-23) in mineral metabolism, innate immunity and adverse cardiovascular outcomes.FGF-23, produced by osteocytes in bone, activates FGFR/α-Klotho (α-Kl) complexes in the kidney. The resulting bone-kidney axis coordinates renal phosphate reabsorption with bone mineralization, and creates a ...
Xiaobin, Han, L Darryl, Quarles
openaire   +2 more sources

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer

open access: yesFrontiers in Cell and Developmental Biology, 2021
Together with fibroblast growth factors (FGFs) 19 and 21, FGF23 is an endocrine member of the family of FGFs. Mainly secreted by bone cells, FGF23 acts as a hormone on the kidney, stimulating phosphate excretion and suppressing formation of 1,25(OH)2D3 ...
Franz Ewendt   +2 more
doaj   +1 more source

Phosphorus Restriction Changes the Expression of Fibroblast Growth Factor 23 and Its Receptors in Laying Hens

open access: yesFrontiers in Physiology, 2020
Dietary phosphorus oversupply wastes non-renewable natural resources and raises environmental concerns in animal agriculture. We hypothesized that laying hens do not need large safety margins for dietary phosphorus because of the existence of fibroblast ...
Zhouzheng Ren   +8 more
doaj   +1 more source

Fibroblast-growth factor 23 promotes terminal differentiation of ATDC5 cells. [PDF]

open access: yesPLoS ONE, 2017
Fibroblast Growth Factor 23 (FGF23) is well documented as a crucial player in the systemic regulation of phosphate homeostasis. Moreover, loss-of-function experiments have revealed that FGF23 also has a phosphate-independent and local impact on ...
Mathilde Guibert   +3 more
doaj   +1 more source

Inflammation regulates fibroblast growth factor 23 production [PDF]

open access: yesCurrent Opinion in Nephrology and Hypertension, 2016
Fibroblast growth factor 23 (FGF23) is a hormone secreted by osteocytes and osteoblasts that regulates phosphorus and vitamin D homeostasis. FGF23 levels increase progressively in chronic kidney disease (CKD), and FGF23 excess might be a causal factor of left ventricular hypertrophy, CKD progression and death.
Connor, Francis, Valentin, David
openaire   +2 more sources

Home - About - Disclaimer - Privacy